Back to company

NOVOZYMES BIOINDUSTRIAL CHINA A/S: Financial statements 2019

CVR: 21599042

NOVOZYMES BIOINDUSTRIAL CHINA A/S (CVR 21599042) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -37,500 and a net result of DKK 283,492,654 compared with DKK -53,650 the year before. Equity amounted to DKK 1,052,111,768. The solvency ratio was 100%.

Gross Profit
-37,500 kr.
Profit/Loss
283,492,654 kr.
Equity
1,052,111,768 kr.
Total Assets
1,052,111,768 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--38 t.283.5 mio.1.1 mia.0
2018--68 t.-54 t.768.6 mio.-
2017--73 t.-58 t.770.2 mio.-
2016--78 t.-61 t.770.2 mio.-
2015--90 t.-69 t.770.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

NOVOZYMES BIOINDUSTRIAL CHINA A/S: The 2018 annual report is outMay 31, 2019

NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2018. Gross profit came to DKK -67,702, and the net result was DKK -53,650.

About NOVOZYMES BIOINDUSTRIAL CHINA A/S

NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lisbet Kragelund. The company is owned by NOVOZYMES A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331.